Cancer Genetics has appointed Glenn Miles as its chief financial officer, effective November 26, 2018. In addition, the company said that Igor Gitelman, its current chief accounting officer, will be departing.
Miles has more than 30 years' experience in a variety of accounting and finance roles and has been a full time contractor with Cancer Genetics since this July. Prior to joining Cancer Genetics, he served as President and CFO of management advisory firm Catalytic Consulting, was biopharma controller for Europe, Latin America and US oncology at Pfizer, and held various senior-level finance positions at Lehman Brothers and AT&T Mobility. He holds an MBA from Mercer University and bachelors in commerce and accounting from the University of Alabama.